ID: MRFR/LS/3490-CR | July 2019 | Region: Global | 117 pages
The Global Glucose Tolerance Test Market is expected to grow at CAGR of 10.4% to reach USD 46,815.0 Million till 2023. A glucose tolerance test measures how well a body’s cells is capable to engross glucose, or sugar, after a patient consume a given amount of sugar. Doctors and specialists use fasting blood sugar levels and haemoglobin A1c values to identify type 1 and type 2 diabetes, and pre-diabetes whereas a glucose tolerance test can also be used. Doctors primarily use a glucose tolerance test to diagnose gestational diabetes in patients. The factors that are anticipated to propel the growth of the global glucose tolerance test market are increasing prevalence and incidence of diabetes mellitus (DM), innovation in technology, research funding in diabetes diagnosis & treatment, and rising awareness & screening for diabetes mellitus. However, the stringent reimbursement and insurance policies in developing nations, high-cost associated with diagnosis and treatment of diabetes can hamper the market growth in coming future.
Rising prevalence and incidence of diabetes mellitus, technological innovations, research funding in diabetes diagnosis & treatment, and awareness & screening for diabetes mellitus are the factors that drive the growth of glucose tolerance tests market. For instance, according to report published by WHO, in 2016, 1.6 million deaths were directly caused by diabetes worldwide. Also, according to the diabetes prevalence figures suggested by the Australian Bureau of Statistics, more than 5.1% of the Australian population diagnosed with diabetes in 2016. Various government and private associations in developed and some developing countries are contributing towards diabetes research and prevention programs. Various researchers have pioneered new devices to diagnose and treat diabetes, which on their own have significant market potential. The main aim of these association is to support and encourage research in the field of diabetes with the rapid diffusion of acquired knowledge to facilitate its application. The spending on diabetes care research ultimately leads to the healthcare delivery.
GLOBAL GLUCOSE TOLERANCE TEST MARKET BY PRODUCTS, 2016 & 2023 (USD MILLION)
Sources: MRFR Analysis
On the basis of product, the global glucose tolerance test market has been segmented into blood glucose testing kit, smart sensors, and others. Blood glucose testing kit segment has been further segmented into lancet, meters, test strips, and others. Blood glucose testing kit is the leading segment, which is expected to hit USD 36,164.0 Million by the end of 2023. The large market share of blood glucose testing kit is due to the easily availability and use, rising prevalence of diabetes and growing demand of home care for diabetes. According to the Centers for Disease Control and Prevention (CDC), type 2 diabetes is responsible for about 90% to 95% of all diagnosed cases of diabetes in adults, further 29.1 million people in the United States have diabetes, but 8.1 million of the diagnosed may be unaware of their condition.
The global glucose tolerance test market, by indication, has been segmented into diabetes, gestational diabetes, insulin resistance, and reactive hypoglycemia. The diabetes segment is expected to show the highest CAGR 10.7% during the forecast period owing to the rising prevalence of diabetes. For instance, according to report published by CDC, in 2015, an estimated 1.5 million new cases of diabetes were diagnosed among people ages 18 and older.
On the bases of end-user market is segmented into diagnostic clinics, hospitals, and home. The diagnostic clinics are expected to hold the largest market share of 34.5% in 2016.
The prominent players in the global glucose tolerance test market are Panasonic, Dexcom, Inc., Abbott Laboratories, F. Hoffman-La Roche Ltd, LifeScan, Inc., Sanofi, Medtronic PLC, and Others
Global Glucose Tolerance Test Market Share, by Region, 2016 (%)
Sources: MRFR Analysis
The global glucose tolerance test market is mainly categorized as the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to dominate the global glucose tolerance test market with market share of 36.9% owing to the to the increasing prevalence of diabetes mellitus (DM), well-developed technology, and high healthcare expenditure. According to the American Diabetes Association, nearly 30 million Americans are dealing with diabetes and every 21 seconds one person is diagnosed with diabetes.
The European glucose tolerance test market has been segmented into Western Europe and Eastern Europe. Western Europe has been further segmented into Germany, France, Italy, Spain, UK, and the rest of Western Europe. Europe holds the second largest market share in the Western Europe region due to the increasing government support for research & development, well-developed healthcare infrastructure, and presence of geriatric population.
Asia-Pacific region expected to register the highest CAGR of 11.0% during the forecast period owing to rapidly changing healthcare sector, and the presence of huge opportunities for the development of this market.
Middle East & Africa is expected to witness a restricted growth due to presence of poor and slow developing countries, especially, in African region.
Some of the key strategies followed by the players operating in the global glucose tolerance test market were innovation, product development, acquisition, and expansion.
Global Glucose Tolerance Test Market, by Product
Global Glucose Tolerance Test Market, by Indication
Global Glucose Tolerance Test Market, by End User
Global Glucose Tolerance Test Market, by Region
Available Additional Customizations
Frequently Asked Questions (FAQ) :
Glucose tolerance test market is projected to grow at a 10.4% CAGR between 2014-2023.
The Americas is expected to dominate the glucose tolerance test market.
Glucose tolerance test market is predicted to touch USD 46,815.0 million by 2023.
Diagnostic clinics will lead the glucose tolerance test market.
High cost of diagnosis may limit the glucose tolerance test market growth.